A laboratory billing audit example is most useful when it shows where revenue breaks down between a completed test and a posted payment. For an independent toxicology or diagnostic laboratory, that gap is rarely caused by one major failure. More often, it is the accumulated effect of incomplete orders, coverage edits, inconsistent charge capture, payer enrollment issues, and follow-up that stops too early.
Consider a fictional independent urine toxicology laboratory processing approximately 4,500 claims per month. Leadership sees that monthly collections have remained flat despite increasing specimen volume. The billing team is working denials, but the laboratory lacks a clear view of which problems are isolated events and which are built into the revenue cycle.
A focused audit turns that uncertainty into an operating plan.
Laboratory Billing Audit Example: The Starting Point
The audit begins with six months of claims, remittance, payment posting, and denial data. The laboratory also provides its payer contracts, fee schedules, ordering documentation requirements, credentialing records, and current billing workflow.
At first glance, the lab’s numbers appear manageable. Its clean-claim rate is 91%, first-pass payment rate is 82%, and accounts receivable over 90 days represents 18% of total receivables. Those figures do not automatically signal a crisis. But for a laboratory operating under reimbursement pressure, each percentage point can represent meaningful cash flow.
The audit team pulls a statistically relevant sample of paid, denied, adjusted, and aging claims. It compares the billed CPT and HCPCS codes, modifiers, diagnosis support, ordering provider information, units, dates of service, and allowed amounts against payer rules and contract expectations. The purpose is not simply to find errors. It is to identify the process that allowed each error to recur.
Finding 1: Denials Were Concentrated in a Few Preventable Categories
The lab’s denial rate was 14%, but the audit found that three categories accounted for nearly two-thirds of denied dollars: medical necessity edits, missing or invalid ordering-provider information, and authorization or coverage limitations.
Medical necessity denials were especially common on certain payer plans and testing profiles. In several cases, the diagnosis information transmitted on the claim did not support the services billed under that payer’s policy. The lab had documentation in the chart, but the diagnosis selection process was inconsistent between the intake team, laboratory information system, and billing platform.
The operational fix was not to ask billers to appeal every denial more aggressively. It was to build payer-specific diagnosis and coverage checks into the front-end workflow, then create a clear escalation path for orders that did not meet documentation requirements. Appeals still had a role, particularly when the clinical record supported the test. However, preventing repeat denials created the stronger financial result.
Finding 2: Paid Claims Were Not Always Paid Correctly
The audit also identified underpayments on claims marked as paid in full. This is a common blind spot. A payment posted without a denial code can look complete, even when the payer allowed less than the contracted rate or incorrectly bundled a service.
In the sample, the laboratory found recurring variances with two commercial payers. One variance stemmed from outdated fee schedule configuration in the billing system. The other involved claims processed under an incorrect network status after a credentialing and enrollment update had not flowed through to the payer’s claims system.
The total underpayment rate was only 3.1% of reviewed paid claims. Yet, when applied to the laboratory’s monthly commercial volume, the projected annual opportunity was substantial. Recovering historical underpayments mattered, but the more valuable improvement came from establishing a contract-variance report that flagged payments outside an acceptable range before accounts were closed.
Finding 3: Charges Reached Billing Too Late
The lab’s average charge lag was 11 days from date of service to claim submission. For a high-volume laboratory, that delay slows cash flow and gives documentation issues more time to become difficult to resolve.
The cause was not a single backlog in billing. Specimens requiring manual review were being held while the team clarified test panels, ordering details, or demographic mismatches. Because those exceptions were tracked in email and spreadsheets rather than a defined work queue, some accounts waited longer than necessary.
The audit recommended a daily exception-management process with ownership by issue type. Demographic corrections, ordering-provider questions, coverage verification concerns, and coding review should not sit in one undifferentiated queue. Each issue needs a turnaround expectation and a responsible role. This is where operational oversight directly improves reimbursement performance.
What the Audit Measured Beyond Denials
A meaningful laboratory billing audit does more than sort claims into paid and denied columns. It measures whether the revenue cycle is producing predictable, contractually accurate results.
For this example, the core scorecard included clean-claim rate, first-pass payment rate, denial rate by root cause and payer, days in accounts receivable, charge lag, net collection rate, appeal overturn rate, and underpayment recovery. The audit also reviewed credentialing status, payer enrollment records, write-off controls, patient balance workflows, and the percentage of claims requiring manual intervention.
These measures work together. A low denial rate may look positive while underpayments increase. Fast claim submission may be counterproductive if the lab sends incomplete claims that create avoidable rework. A strong appeal rate can signal capable follow-up, but it can also reveal that front-end controls are failing.
The right benchmark depends on the laboratory’s test mix, payer concentration, state footprint, participation status, and documentation model. The goal is not to force every lab into a generic metric. The goal is to establish a reliable baseline, identify revenue leakage, and monitor whether corrective actions improve the economics of the business.
Turning Findings Into a 90-Day Plan
The laboratory in this example did not attempt to fix every issue at once. It prioritized the changes with the clearest revenue impact and the least disruption to laboratory operations.
During the first 30 days, the team corrected payer enrollment discrepancies, updated fee schedules, and assigned ownership for high-dollar underpayment review. It also created a denial matrix showing the top denial reasons by payer, test category, and location.
Over the next 30 days, the lab standardized order-review requirements and added front-end edits for recurring documentation and diagnosis issues. Billing staff received targeted guidance based on the actual denial patterns rather than broad retraining that consumes time without changing behavior.
By day 90, leadership reviewed performance against the baseline. The expected indicators were lower preventable denials, shorter charge lag, faster resolution of exceptions, and improved identification of payment variances. Just as important, the laboratory had a repeatable governance process: regular reporting, accountable owners, and a defined method for escalating payer and workflow issues.
When an Audit Should Go Deeper
Some situations require a broader review. A sudden payer termination, declining reimbursement on a key test line, a change in utilization patterns, rapid growth into new states, or aging accounts that continue to rise can point to issues beyond routine billing follow-up.
In those cases, the audit should extend into payer strategy, credentialing, test-menu economics, ordering-provider education, patient billing, and technology configuration. A billing problem may begin with a claim, but its root cause may sit upstream in contracting, intake, documentation, or operational design.
Revenue Management Corporation approaches laboratory revenue performance as a whole-business issue. The strongest result comes when billing, reimbursement oversight, credentialing, and operational accountability work from the same financial plan.
A good audit does not end with a spreadsheet of errors. It gives laboratory leaders a practical view of what to correct first, what to monitor every month, and where disciplined revenue cycle management can support healthier growth.
Recent Comments